caseintelcaseintel
← Back to Dashboard
Litigation Stage Tracker
Rapid Growth

Talcum Powder (Cosmetic)

OpenFAST
Consumer
500+
Total Cases

Causation

Plaintiffs allege cosmetic-grade talc is frequently contaminated with asbestos fibers due to geological co-occurrence of talc and asbestos deposits. Perineal application of talc-containing cosmetic powders enables asbestos fiber migration to the ovaries, causing chronic inflammation and malignant transformation. IARC classifies perineal talc use as 'possibly carcinogenic' (Group 2B). FDA testing in 2019-2020 found asbestos in multiple cosmetic products from various retailers.

Defendants

EntityRoleNote
Revlon Inc.ManufacturerTalc-containing cosmetic powders and foundations
Coty Inc.ManufacturerCover Girl, Rimmel, and other talc-based cosmetics
Estee Lauder CompaniesManufacturerMAC, Clinique, and other prestige cosmetic brands using talc
Colgate-PalmoliveManufacturerCashmere Bouquet talc products
Imerys Talc AmericaTalc SupplierMajor talc mining and processing company — filed Chapter 11

Litigation Timeline

2006
IARC classifies perineal talc use as Group 2B — possibly carcinogenic
2019
FDA finds asbestos in Claire's and other retail cosmetic products
Feb 2020
Imerys Talc America files Chapter 11 bankruptcy
2023-2024
Lawsuits filed against non-J&J cosmetic talc manufacturers accelerate
2025
Plaintiff firms building inventory separate from J&J MDL
2026
~500 cases filed. MDL consolidation petition possible

Intelligence Signals

No signals yet. Signals populate automatically when scrapers run.

Key Facts

Status
active

Geographic Exposure

·Various federal districts (Pre-MDL — no consolidation yet)
·New Jersey (significant filings — Imerys bankruptcy venue)
·Missouri (favorable plaintiff jurisdiction)
·California, Illinois (active filing states)

Eligibility Criteria

  • Used talc-containing cosmetic products (body powder, face powder, foundation)
  • Diagnosed with ovarian cancer
  • Regular use of talc products in perineal or genital area
  • Product was not manufactured by Johnson & Johnson (separate MDL 2738)